secwatch.observer — SEC 8-K summary
======================================

Issuer:     Raphael Pharmaceutical Inc. (RAPH)
CIK:        0001415397
Form:       8-K
Filed at:   2024-06-26T23:59:59+00:00
Accession:  0001213900-24-056191
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Raphael Pharmaceutical increases authorized common shares to 50M (from 21M)
---------------------------------------------------------------------------

- Authorized common shares increased from 21,020,560 to 50,000,000 effective June 26, 2024.
- Board approved the increase on May 9, 2024; majority shareholders approved on May 22, 2024.
- Company filed Amended and Restated Articles of Incorporation with Nevada Secretary of State.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1415397/000121390024056191/0001213900-24-056191-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1415397/000121390024056191/ea0208572-8k_raphael.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-056191

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer